http://www.xconomy.com/boston/2013/04/1 ... dsourcing/
This concept gives new hope to the thought that therapies that cannot be patented could still gain the statistically significant status needed to be accepted by the medical community.
There is a wealth of anecdotal data supporting things like:
Wheldon Protocol (ABX antibiotic regimens)
Procarin / histamine (Prokarin)
Low Dose Naltrexone (LDN)
Swank diet & supplement regimen
But these potentially life-altering therapies aren't even mentioned by doctors (normally) because there haven't been (and won't likely be) any multimillion dollar clinical trials to prove statistical significance. By setting the precedent for crowdsourcing clinical trials, Transparency Life Sciences is lowering the barrier to entry, providing hope for therapies that don't have billion dollar potential (which are currently neglected).